In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice

Clinical and Experimental Metastasis

Volumn 29, Issue 6, 2012, Pages 573-583

  Pichorner, Andreas ^a   Sack, Ulrike ^b   Kobelt, Dennis ^b   Kelch, Inken ^a   Arlt, Franziska ^a   Smith, Janice ^b   Walther, Wolfgang ^a   Schlag, Peter M ^a   Stein, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Colorectal cancer; In vivo imaging; MACC1; Metastasis; Real time monitoring; ShRNA treatment

Indexed keywords

LUCIFERASE; METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; PROTEIN; PROTEIN SH3; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CANCER GROWTH; CELL MOTILITY; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LIVER METASTASIS; MOUSE; NONHUMAN; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENES, REPORTER; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84863726773     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9472-6     Document Type: Article

References (37)

1. Stein U, Schlag PM (2007) Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res 176:61-80
2. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging. J Natl Cancer Inst 96:1420-1425
3. Di Costanzo F, Doni L (2005) Adjuvant therapy in colon cancer: which treatment in 2005? Ann Oncol 16 (Suppl 4): iv69-iv73
4. Macdonald JS (1997) Adjuvant therapy for colon cancer. CA Cancer J Clin 47:243-256
5. Morris EJ, Forman D, Thomas JD et al (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97:1110-1118
6. Stein U, Walther W, Arlt F et al (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15:59-67
7. Shirahata A, Shinmura K, Kitamura Y et al (2010) MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res 30:2689-2692
8. Galimi F, Torti D, Sassi F et al (2011) Genetic expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to Met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res 17:3146-3156
9. Shirahata A, Sakata M, Kitamura Y et al (2010) MACC1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res 30:3441-3444
10. Shimokawa H, Uramoto H, Onitsuka T et al (2011) Overex-pression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg 141: 895-898
11. Chundong G, Uramoto H, Onitsuka T et al (2011) Molecular diagnosis of MACC1 status in lung adenocarcinoma by immu-nohistochemical analysis. Anticancer Res 31:1141-1145
12. Shirahata A, Fan W, Sakuraba K et al (2011) MACC1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 31:777-780
13. Qiu J, Huang P, Liu Q et al (2011) Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 9:166
14. Stein U, Dahlmann M, Walther W (2010) MACC1-more than metastasis? Facts and predictions about a novel gene. J Mol Med 88:11-18
15. Kokoszyńska K, Kryński J, Rychlewski L et al (2009) Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56:317-323
16. Martin GS (2001) The hunting of the Src. Nat Rev Mol Cell Biol 2:467-475
17. Lu XL, Cao X, Liu XY et al (2010) Recent progress of Src SH2 and SH3 Inhibitors as anticancer agents. Curr Med Chem 17: 1117-1124
18. Birchmeier C, Birchmeier W, Gherardi E et al (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915-925
19. Stein U, Smith J, Walther W et al (2009) MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 8:2467-2469
20. Arlt F, Stein U (2009) Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 41:2356-2359
21. Servais EL, Colovos C, Bograd AJ et al (2011) Animal models and molecular imaging tools to investigate lymph node metastases. J Mol Med 89:753-769
22. Albini A, Iwamoto Y, Kleinman HK et al (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245
23. Marquet RL, van den Tol MP, Jeekell J (2001) Sodium hyalu-ronate enhances colorectal tumour cell metastatic potential in vitro and in vivo. Br J Surg 88:246-250
24. Zumsteg A, Strittmatter K, Klewe-Nebenius D et al (2010) A bioluminescent mouse model of pancreatic {beta}-cell carcino-genesis. Carcinogenesis 31:1465-1474
25. McNally LR, Welch DR, Beck BH et al (2010) KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis 27:591-600
26. Shin JH, Chung JK, Kang JH et al (2004) Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene. J Nucl Med 45:2109-2115
27. Naylor LH (1999) Reporter gene technology: the future looks bright. Biochem Pharmacol 58:749-757
28. Contag CH, Jenkins D, Contag PR et al (2000) Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2:41-52
29. Welsh S, Kay SA (1997) Reporter gene expression for monitoring gene transfer. Curr Opin Biotechnol 8:617-622
30. Jenkins DE, Oei Y, Hornig YS et al (2003) Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20:733-744
31. Dinca EB, Sarkaria JN, Schroeder MA et al (2007) Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg 107:610-616
32. Rehemtulla A, Stegman LD, Cardozo SJ et al (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491-495
33. Paroo Z, Bollinger RA, Braasch DA et al (2004) Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3:117-124
34. Sack U, Walther W, Scudiero D et al (2011) S100A4-induced cell motility and metastasis is restricted by the Wnt/{beta}-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell 22:3344-3354
35. Yamaguchi H, Wyckoff J, Condeelis J (2005) Cell migration in tumors. Curr Opin Cell Biol 17:559-564
36. Suresh S (2007) Biomechanics and biophysics of cancer cells. Acta Biomater 3:413-438
37. Mizuguchi H, Xu Z, Ishii-Watabe A et al (2000) IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1:376-382